Literature DB >> 23468462

Short telomere length, cancer survival, and cancer risk in 47102 individuals.

Maren Weischer1, Børge G Nordestgaard, Richard M Cawthon, Jacob J Freiberg, Anne Tybjærg-Hansen, Stig E Bojesen.   

Abstract

BACKGROUND: Recent meta-analyses have suggested that short telomere length was associated with increased risk of cancer. We therefore tested the hypotheses that short telomere length was associated with increased risk of cancer and with increased risk of early death after cancer.
METHODS: We measured leukocyte telomere length in a prospective study of 47 102 Danish general population participants from the Copenhagen City Heart Study and the Copenhagen General Population Study. Participants were followed for up to 20 years for cancer diagnosis and death. Follow-up was 100% complete. All statistical tests were two-sided.
RESULTS: Telomere length decreased linearly with increasing age (P <.001). During follow-up, we observed 3142 first cancers and, among these individuals, 1730 deaths. Decreasing quartiles of telomere length were associated with decreasing survival after cancer (log-rank P <.001). Multivariable-adjusted hazard ratios of early death were 1.31 (95% confidence interval [CI] = 1.14 to 1.52) in individuals in the quartile and 1.43 (95% CI = 1.13 to 1.80) in individuals in the decile with the shortest telomeres vs the longest. Unadjusted hazard ratios of cancer risk were 1.74 (95% CI = 1.58 to 1.93) and 2.00 (95% CI = 1.70 to 2.35) in individuals in the quartile and decile with the shortest vs longest telomeres; however, multivariable adjustment changed these hazard ratios to 0.98 (95% CI = 0.88 to 1.08) and 0.95 (95% CI = 0.80 to 1.11), mainly because of age adjustment.
CONCLUSIONS: Short telomere length is associated with reduced survival after cancer but not with cancer risk. The latter contrasts with findings from recent meta-analyses.

Entities:  

Mesh:

Year:  2013        PMID: 23468462     DOI: 10.1093/jnci/djt016

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  108 in total

1.  U-shaped association between telomere length and esophageal squamous cell carcinoma risk: a case-control study in Chinese population.

Authors:  Jiangbo Du; Wenjie Xue; Yong Ji; Xun Zhu; Yayun Gu; Meng Zhu; Cheng Wang; Yong Gao; Juncheng Dai; Hongxia Ma; Yue Jiang; Jiaping Chen; Zhibin Hu; Guangfu Jin; Hongbing Shen
Journal:  Front Med       Date:  2015-11-18       Impact factor: 4.592

2.  Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinoma.

Authors:  Enping Xu; Wenjie Sun; Jian Gu; Wong-Ho Chow; Jaffer A Ajani; Xifeng Wu
Journal:  Carcinogenesis       Date:  2013-06-26       Impact factor: 4.944

3.  Leukocyte telomere length in relation to risk of lung adenocarcinoma incidence: Findings from the Singapore Chinese Health Study.

Authors:  Jian-Min Yuan; Kenneth B Beckman; Renwei Wang; Caroline Bull; Jennifer Adams-Haduch; Joyce Y Huang; Aizhen Jin; Patricia Opresko; Anne B Newman; Yun-Ling Zheng; Michael Fenech; Woon-Puay Koh
Journal:  Int J Cancer       Date:  2018-01-25       Impact factor: 7.396

4.  Telomere length and cancer mortality in American Indians: the Strong Heart Study.

Authors:  Pooja Subedi; Stefano Nembrini; Qiang An; Yun Zhu; Hao Peng; Fawn Yeh; Shelley A Cole; Dorothy A Rhoades; Elisa T Lee; Jinying Zhao
Journal:  Geroscience       Date:  2019-06-22       Impact factor: 7.713

5.  Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Authors:  Linda Kachuri; Jens Helby; Stig Egil Bojesen; David C Christiani; Li Su; Xifeng Wu; Adonina Tardón; Guillermo Fernández-Tardón; John K Field; Michael P Davies; Chu Chen; Gary E Goodman; Frances A Shepherd; Natasha B Leighl; Ming S Tsao; Yonathan Brhane; M Catherine Brown; Kevin Boyd; Daniel Shepshelovich; Lei Sun; Christopher I Amos; Geoffrey Liu; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

6.  Telomere length as a risk factor for hereditary prostate cancer.

Authors:  Lauren M Hurwitz; Christopher M Heaphy; Corinne E Joshu; William B Isaacs; Yuko Konishi; Angelo M De Marzo; Sally D Isaacs; Kathy E Wiley; Elizabeth A Platz; Alan K Meeker
Journal:  Prostate       Date:  2013-11-28       Impact factor: 4.104

7.  Leukocyte telomere length and ideal cardiovascular health in American Indians: the Strong Heart Family Study.

Authors:  Hao Peng; Mihriye Mete; Sameer Desale; Amanda M Fretts; Shelley A Cole; Lyle G Best; Jue Lin; Elizabeth Blackburn; Elisa T Lee; Barbara V Howard; Jinying Zhao
Journal:  Eur J Epidemiol       Date:  2016-09-22       Impact factor: 8.082

8.  Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.

Authors:  Marco Benati; Martina Montagnana; Elisa Danese; Martina Mazzon; Elisa Paviati; Simone Garzon; Antonio Simone Laganà; Jvan Casarin; Silvia Giudici; Ricciarda Raffaelli; Fabio Ghezzi; Massimo Franchi; Giuseppe Lippi
Journal:  Pathol Oncol Res       Date:  2020-05-27       Impact factor: 3.201

9.  Resilience to adversity and the early origins of disease.

Authors:  Gene H Brody; Tianyi Yu; Steven R H Beach
Journal:  Dev Psychopathol       Date:  2016-10-03

10.  Telomere Length is a Susceptibility Marker for Tasmanian Devil Facial Tumor Disease.

Authors:  Lane E Smith; Menna E Jones; Rodrigo Hamede; Rosana Risques; Austin H Patton; Patrick A Carter; Andrew Storfer
Journal:  Ecohealth       Date:  2020-10-30       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.